소병진행 신세포암종: 수술의 역할은 무엇인가?

Re 등(Mon,)이 이 질문을 연구하였다.

www.synapsesocial.com/papers/69df2ae6e4eeef8a2a6afd9c — DOI: https://doi.org/10.1111/bju.70281

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Complete Response in Metastatic Clear Cell Renal Cell Carcinoma Patients Treated with Immune-Checkpoint Inhibitors: Remission or Healing? How to Improve Patients’ Outcomes?· 2023 · 21 citations
2. Survival after complete surgical resection of multiple metastases from renal cell carcinoma· 2011 · 428 citations
3. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial· 2023 · 81 citations
4. Utility of PSMA PET/CT in Staging and Restaging of Renal Cell Carcinoma: A Systematic Review and Metaanalysis· 2024 · 24 citations
5. Surgical Safety of Deferred Cytoreductive Nephrectomy Following Pretreatment with Immune Checkpoint Inhibitor–based Dual Combination Therapy· 2021 · 28 citations